by Nikoletta Rovina, Karolina Akinosoglou, Jesper
Eugen-Olsen, Salim Hayek, Jochen Reiser and Evangelos J. Giamarellos-Bourboulis
As of April 1, 2020, 885,689 cases of infections by the
novel coronavirus SARS-CoV-2 (COVID-19) have been recorded worldwide; 44,217 of
them have died (https://www.worldometers.info/coronavirus).
At the beginning of the illness, patients may experience low-degree fever or
flu-like symptoms, but suddenly, severe respiratory failure (SRF) emerges [1].
Increased circulating levels of D-dimers [1, 2]
suggest endothelial activation. Urokinase plasminogen activator receptor (uPAR)
that is bound on the endothelium may be cleaved early during the disease course
leading to an increase of its soluble counterpart, namely suPAR [3].
If this holds true, then suPAR may be used as an early predictor of the risk of
SRF…
No comments:
Post a Comment